ALX Oncology Holdings Inc ALXO:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/10/24 EDT
16.21UNCH (UNCH)
Volume
5,357
Close
16.21quote price arrow down-0.74 (-4.37%)
Volume
383,282
52 week range
3.94 - 17.83
Loading...
  • Open17.50
  • Day High17.50
  • Day Low15.94
  • Prev Close16.95
  • 52 Week High17.83
  • 52 Week High Date05/07/24
  • 52 Week Low3.94
  • 52 Week Low Date08/31/23

Key Stats

  • Market Cap818.586M
  • Shares Out50.50M
  • 10 Day Average Volume0.65M
  • Dividend-
  • Dividend Yield-
  • Beta1.29
  • YTD % Change8.87

KEY STATS

  • Open17.50
  • Day High17.50
  • Day Low15.94
  • Prev Close16.95
  • 52 Week High17.83
  • 52 Week High Date05/07/24
  • 52 Week Low3.94
  • 52 Week Low Date08/31/23
  • Market Cap818.586M
  • Shares Out50.50M
  • 10 Day Average Volume0.65M
  • Dividend-
  • Dividend Yield-
  • Beta1.29
  • YTD % Change8.87

RATIOS/PROFITABILITY

  • EPS (TTM)-3.74
  • P/E (TTM)-4.33
  • Fwd P/E (NTM)-4.94
  • EBITDA (TTM)-168.985M
  • ROE (TTM)-70.97%
  • Revenue (TTM)-
  • Gross Margin (TTM)9.11%
  • Net Margin (TTM)-10,336.05%
  • Debt To Equity (MRQ)6.29%

EVENTS

  • Earnings Date08/08/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On ALX Oncology Holdings Inc

 

Profile

MORE
ALX Oncology Holdings Inc. is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing therapies that block the CD47 immune checkpoint inhibitor and bridge the innate and adaptive immune system. Its product candidate, evorpacept, is a CD47 blocking therapeutic that combines a high-affinity CD47 binding domain with an inactivated, proprietary Fc domain. It is engaged in focusing on combining evorpacept with anti-cancer antibodies, ADCs...
Corey Goodman
Executive Chairman of the Board
Jason Lettmann
Chief Executive Officer, Director
Jaume Pons Ph.D.
President, Chief Scientific Officer
Peter Garcia CPA
Chief Financial Officer
Shelly Pinto
Chief Accounting Officer, Vice President - Finance
Address
323 Allerton Avenue
South San Francisco, CA
94080
United States

Top Peers

SYMBOLLASTCHG%CHG
DNTH
Dianthus Therapeutics Inc
24.29-0.64-2.57%
IRON
Disc Medicine Inc
30.36-0.41-1.33%
AUTL
Autolus Therapeutics PLC
3.99-0.18-4.32%
LBPH
Longboard Pharmaceuticals Inc
20.12-1.87-8.50%
COGT
Cogent Biosciences Inc
7.56-0.36-4.55%